IT1178455B - Soluzioni di insulina stabilizzate e metodi per la loro produzione - Google Patents

Soluzioni di insulina stabilizzate e metodi per la loro produzione

Info

Publication number
IT1178455B
IT1178455B IT19420/83A IT1942083A IT1178455B IT 1178455 B IT1178455 B IT 1178455B IT 19420/83 A IT19420/83 A IT 19420/83A IT 1942083 A IT1942083 A IT 1942083A IT 1178455 B IT1178455 B IT 1178455B
Authority
IT
Italy
Prior art keywords
production
methods
insulin solutions
stabilized insulin
stabilized
Prior art date
Application number
IT19420/83A
Other languages
English (en)
Italian (it)
Other versions
IT8319420A0 (it
Inventor
Jens Jorgen Vejlgaard Brange
Svend Havelund
Original Assignee
Novo Industri As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Industri As filed Critical Novo Industri As
Publication of IT8319420A0 publication Critical patent/IT8319420A0/it
Application granted granted Critical
Publication of IT1178455B publication Critical patent/IT1178455B/it

Links

Classifications

    • H—ELECTRICITY
    • H05—ELECTRIC TECHNIQUES NOT OTHERWISE PROVIDED FOR
    • H05K—PRINTED CIRCUITS; CASINGS OR CONSTRUCTIONAL DETAILS OF ELECTRIC APPARATUS; MANUFACTURE OF ASSEMBLAGES OF ELECTRICAL COMPONENTS
    • H05K13/00—Apparatus or processes specially adapted for manufacturing or adjusting assemblages of electric components
    • H05K13/06—Wiring by machine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Microelectronics & Electronic Packaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Manufacturing & Machinery (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
IT19420/83A 1982-02-05 1983-02-04 Soluzioni di insulina stabilizzate e metodi per la loro produzione IT1178455B (it)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DK49182 1982-02-05

Publications (2)

Publication Number Publication Date
IT8319420A0 IT8319420A0 (it) 1983-02-04
IT1178455B true IT1178455B (it) 1987-09-09

Family

ID=8094159

Family Applications (1)

Application Number Title Priority Date Filing Date
IT19420/83A IT1178455B (it) 1982-02-05 1983-02-04 Soluzioni di insulina stabilizzate e metodi per la loro produzione

Country Status (22)

Country Link
US (1) US4476118A (OSRAM)
JP (1) JPS58192818A (OSRAM)
AT (1) AT382780B (OSRAM)
AU (1) AU549981B2 (OSRAM)
BE (1) BE895832A (OSRAM)
CA (1) CA1203476A (OSRAM)
CH (1) CH657530A5 (OSRAM)
DE (1) DE3303860A1 (OSRAM)
ES (1) ES519533A0 (OSRAM)
FI (1) FI78616C (OSRAM)
FR (1) FR2521009B1 (OSRAM)
GB (1) GB2114573B (OSRAM)
GR (1) GR77388B (OSRAM)
IE (1) IE54548B1 (OSRAM)
IT (1) IT1178455B (OSRAM)
LU (1) LU84632A1 (OSRAM)
NL (1) NL187269C (OSRAM)
NO (1) NO161204C (OSRAM)
NZ (1) NZ203189A (OSRAM)
PT (1) PT76195B (OSRAM)
SE (1) SE460948B (OSRAM)
ZA (1) ZA83742B (OSRAM)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0166971B1 (de) * 1984-06-09 1990-02-28 Hoechst Aktiengesellschaft Insulinzubereitungen, Verfahren zu deren Herstellung und deren Verwendung
JP2520262B2 (ja) * 1987-08-21 1996-07-31 春幸 川原 パツチテスト材料
US4789660A (en) * 1987-09-10 1988-12-06 American Home Products Corporation Insulin administration using methyl and propyl paraben
US5130298A (en) * 1989-05-16 1992-07-14 Ethicon, Inc. Stabilized compositions containing epidermal growth factor
US5534488A (en) * 1993-08-13 1996-07-09 Eli Lilly And Company Insulin formulation
US5474978A (en) * 1994-06-16 1995-12-12 Eli Lilly And Company Insulin analog formulations
AR002976A1 (es) * 1995-03-31 1998-05-27 Lilly Co Eli Formulaciones farmaceuticas parenterales de efecto prolongado de insulina; cristales de dichos analogos aplicables en dichas formulaciones yprocedimiento de las formulaciones mencionadas
WO1997017945A2 (en) * 1995-11-13 1997-05-22 Minimed, Inc. Methods and compositions for the delivery of monomeric proteins
EP0891419A4 (en) * 1996-03-12 2000-03-01 Life Technologies Inc NUTRIENT ADDITIVE FOR HEMATOPOETIC CELL CULTURES
DE59711533D1 (de) * 1996-07-26 2004-05-27 Aventis Pharma Gmbh Insulinderivate mit erhöhter Zinkbindung
CO4750643A1 (es) * 1997-06-13 1999-03-31 Lilly Co Eli Formulacion estable de la insulina que contiene l-arginina y protamina
SI0884053T1 (en) * 1997-06-13 2003-02-28 Eli Lilly And Company Stable insulin formulations
JP2001522815A (ja) * 1997-11-12 2001-11-20 アルザ コーポレイション ポリペプチド類の自己会合を減少させる方法
DE19825447A1 (de) 1998-06-06 1999-12-09 Hoechst Marion Roussel De Gmbh Neue Insulinanaloga mit erhöhter Zinkbildung
ES2177323T3 (es) * 1998-10-16 2002-12-01 Novo Nordisk As Preparaciones de insulina concentradas estables para la administracionpor via pulmonar.
DE19930676B4 (de) * 1999-07-02 2006-01-19 Sanofi-Aventis Deutschland Gmbh Verfahren zur Stabilisierung von Insulin, Insulinderivaten und/oder deren Vorläufer in komplexen Mischungen bei deren Lagerung in wäßrigen Lösungsmitteln
WO2001072323A2 (en) * 2000-03-24 2001-10-04 Genentech, Inc. Use of insulin for the treatment of cartilagenous disorders
JP4147234B2 (ja) * 2004-09-27 2008-09-10 キヤノン株式会社 吐出用液体、吐出方法、カートリッジ及び吐出装置
ATE496064T1 (de) 2002-05-07 2011-02-15 Novo Nordisk As Lösliche formulierungen, die monomeres insulin und acyliertes insulin enthalten
EP1585541B1 (en) * 2002-12-20 2007-11-14 Novo Nordisk A/S Pharmaceutical compositions comprising insulin and legends of insulin hexamer
US20050065066A1 (en) * 2002-12-20 2005-03-24 Kaarsholm Niels Christian Stabilised insulin compositions
WO2004096266A1 (en) * 2003-05-02 2004-11-11 Novo Nordisk A/S Improved physical stability of insulin formulations
WO2005012347A2 (en) * 2003-08-05 2005-02-10 Novo Nordisk A/S Novel insulin derivatives
PT1773878E (pt) 2004-07-19 2015-06-05 Biocon Ltd Conjugados de insulina-oligómero, formulaçôes e usos dos mesmos
PT1969004E (pt) * 2005-12-28 2011-11-25 Novo Nordisk As Composições que compreendem uma insulina acilada e zinco e método para criar tais composições
US20090136538A1 (en) * 2006-05-22 2009-05-28 Jan Jezek Stable vaccine formulation
GB0700523D0 (en) * 2007-01-11 2007-02-21 Insense Ltd The Stabilisation Of Proteins
WO2008112706A1 (en) 2007-03-13 2008-09-18 Nutrition 21, Inc. Methods and compositions for the sustained release of chromium
US9034818B2 (en) * 2007-06-13 2015-05-19 Novo Nordisk A/S Pharmaceutical formulations comprising an insulin derivative
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
DK2597103T3 (en) * 2007-11-16 2017-02-13 Novo Nordisk As Stable pharmaceutical compositions comprising liraglutide and degludec
EP2341940A1 (en) * 2008-07-16 2011-07-13 Arecor Limited The stabilisation of proteins
EP2328607A1 (en) * 2008-07-16 2011-06-08 Arecor Limited Stable formulation of a therapeutic protein
ES2607003T3 (es) * 2008-10-30 2017-03-28 Novo Nordisk A/S Tratamiento de diabetes mellitus utilizando inyecciones de insulina con una frecuencia de inyección inferior a la diaria
US9060927B2 (en) 2009-03-03 2015-06-23 Biodel Inc. Insulin formulations for rapid uptake
JP6049625B2 (ja) 2010-10-27 2016-12-21 ノヴォ ノルディスク アー／エス 様々な注射間隔を用いて施されるインスリン注射を使用する、真性糖尿病の治療
EP4070801A1 (en) 2011-03-01 2022-10-12 Nutrition 21, LLC Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
EP2919804B1 (fr) 2012-11-13 2018-01-31 Adocia Formulation à action rapide d'insuline comprenant un composé anionique substitué
US9707275B2 (en) 2012-12-19 2017-07-18 Wockhardt Limited Stable aqueous composition comprising human insulin or an analogue or derivative thereof
JP2016505601A (ja) 2012-12-26 2016-02-25 ウォックハート リミテッド 医薬組成物
TWI641381B (zh) * 2013-02-04 2018-11-21 法商賽諾菲公司 胰島素類似物及／或胰島素衍生物之穩定化醫藥調配物
US10137172B2 (en) 2013-04-30 2018-11-27 Novo Nordisk A/S Administration regime
US9822158B2 (en) * 2013-12-04 2017-11-21 Merck Sharp & Dohme Corp. Method for preparing crystalline insulin
AR102869A1 (es) 2014-12-16 2017-03-29 Lilly Co Eli Composiciones de insulina de rápida acción
JO3749B1 (ar) 2015-08-27 2021-01-31 Lilly Co Eli تركيبات إنسولين سريعة المفعول
MX2018009748A (es) 2016-02-11 2019-02-07 Nutrition 21 Llc Composiciones que contienen cromo para mejorar la salud y el estado físico.
ES2954180T3 (es) * 2016-09-29 2023-11-20 Arecor Ltd Formulación farmacéutica que comprende un compuesto de insulina
EA201992351A1 (ru) 2017-06-01 2020-03-26 Эли Лилли Энд Компани Быстродействующие композиции инсулина
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin
CN114096269B (zh) 2019-07-12 2024-06-11 诺和诺德股份有限公司 高浓度胰岛素制剂
CN120142500B (zh) * 2025-02-28 2025-10-10 中国计量科学研究院 一种具有互换性的活性人胰岛素溶液标准物质及其制备方法和应用

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2882202A (en) * 1950-04-05 1959-04-14 Novo Terapeutisk Labor As Insulin crystal preparations and methods of producing them
US2787575A (en) * 1950-11-22 1957-04-02 Organon Zinc-glycine-insulin composition and production thereof
US2882203A (en) * 1951-06-26 1959-04-14 Novo Terapeutisk Labor As Injectable insulin preparation with protracted effect
DE1044360B (de) * 1953-08-19 1958-11-20 Roskilde Medical Company Ltd R Verfahren zur Herstellung von Zinkinsulin mit erhoehtem Zinkgehalt
DE956098C (de) * 1954-02-18 1957-01-10 Dr Dr Guenther Weitzel Verfahren zur Herstellung zinkreicher Insulin-Komplexverbindungen
US3058885A (en) * 1957-06-08 1962-10-16 Novo Terapeutisk Labor As Process for treatment of insulin crystals and for production of insulin preparationstherefrom
US3014842A (en) * 1957-08-10 1961-12-26 Novo Terapeutish Lab A S Injectable bovine insulin crystal suspensions and process of producing same
US3091573A (en) * 1958-05-12 1963-05-28 Novo Terapeutisk Labor As Quick acting insulin preparation
FR1263220A (fr) * 1958-08-01 1961-06-09 Novo Terapeutisk Labor As Procédé de production d'une préparation d'insuline à action rapide
DK116527B (da) * 1967-03-01 1970-01-19 Nordisk Insulinlab Fremgangsmåde til fremstilling af en hurtigtvirkende, holdbar, neutral opløsning af rent krystallinsk okseinsulin eller okseinsulin, der ved tilsætning af Zn er krystalliserbart i vand, eller blandinger af okseinsulin og insulin af anden oprindelse.
GB1285023A (en) * 1968-08-09 1972-08-09 Novo Terapeutisk Labor As Improvements in or relating to injectable insulin preparations
US3657425A (en) * 1969-03-12 1972-04-18 Burroughs Wellcome Co Beef insulin preparations
DE2459515C3 (de) * 1974-12-17 1982-02-11 Hoechst Ag, 6000 Frankfurt Arzneimittelzubereitungen mit antidiabetischer Wirkung
DE3064888D1 (en) * 1979-04-30 1983-10-27 Hoechst Ag Aqueous solutions of proteins stable against denaturization, process for their manufacture, and their utilization
DK80781A (da) * 1980-02-29 1981-08-30 Hospital For Sick Children Oploesninger af polypeptider
ES8403723A1 (es) * 1982-03-03 1984-04-16 Nordisk Insulinlab Procedimiento de producir preparaciones de insulina.

Also Published As

Publication number Publication date
ES8500060A1 (es) 1984-10-16
SE460948B (sv) 1989-12-11
NL187269B (nl) 1991-03-01
NO161204B (no) 1989-04-10
IE54548B1 (en) 1989-11-08
BE895832A (fr) 1983-08-04
NO830385L (no) 1983-08-08
JPS58192818A (ja) 1983-11-10
FI830375A0 (fi) 1983-02-03
CA1203476A (en) 1986-04-22
FI830375L (fi) 1983-08-06
FR2521009A1 (fr) 1983-08-12
AT382780B (de) 1987-04-10
PT76195B (en) 1986-01-27
AU549981B2 (en) 1986-02-20
NL187269C (nl) 1991-08-01
DE3303860A1 (de) 1983-08-18
CH657530A5 (de) 1986-09-15
AU1113683A (en) 1983-08-11
IE830220L (en) 1983-08-05
NO161204C (no) 1989-07-19
LU84632A1 (fr) 1983-09-08
GB2114573A (en) 1983-08-24
SE8300598D0 (sv) 1983-02-04
FI78616B (fi) 1989-05-31
SE8300598L (sv) 1983-08-06
NZ203189A (en) 1985-07-31
ATA38983A (de) 1986-09-15
ZA83742B (en) 1983-11-30
PT76195A (en) 1983-03-01
ES519533A0 (es) 1984-10-16
GB8303133D0 (en) 1983-03-09
US4476118A (en) 1984-10-09
JPH0367056B2 (OSRAM) 1991-10-21
GR77388B (OSRAM) 1984-09-11
DE3303860C2 (OSRAM) 1989-12-28
FR2521009B1 (fr) 1987-07-17
IT8319420A0 (it) 1983-02-04
FI78616C (fi) 1989-09-11
GB2114573B (en) 1985-05-01
NL8300440A (nl) 1983-09-01

Similar Documents

Publication Publication Date Title
IT1178455B (it) Soluzioni di insulina stabilizzate e metodi per la loro produzione
IT8424069A0 (it) Processo per la produzione di pellicole porose.
IT8220038A0 (it) Preparazione di insulina stabilizzate e metodo per la loro produzione.
IT1167444B (it) Processo e dispositivo per la produzione di profilati
IT1215970B (it) Procedimento e macchina per la fabbricazione di sigarette con filtro.
IT1178948B (it) Procedimento per la produzione di fenilanina
IT8424104A0 (it) 5-pirimidincarbossammidi e tiocarbossammidi processo per la loro produzione e composizioni farmaceutiche contenenti le stesse
IT1178858B (it) Procedimento per la produzione di triptofano
TR21940A (tr) Alkol ueretme yoentemleri
IT1173673B (it) 3-vinil-3-cefem derivati 7-sostituiti e procedimenti per la loro produzione
IT1212543B (it) Composti stilben-azo-derivati o stilben-azossi derivato,procedimenti per la loro produzioe ed il loro impiego
IT1172247B (it) Solfobetaine e procentimento per la loro produzione
FI862363A7 (fi) Menetelmä lastulevyjen valmistamiseksi.
IT1173751B (it) Farmaci contenenti muzolimin,loro impiego e procedimenti per la loro produzione
IT1209936B (it) L-serina metodo per la produzione di
IT8521494A0 (it) Processo per la produzione di para-chinoni.
IT1148404B (it) 2-fenil-2h-1,2,3-triazoli,procedimenti per la loro produzione e loro impiego
IT8348886A0 (it) Acetanilidi basiche, procedimento per la loro produzione e medicamenti che le contengono
IT1143464B (it) Corpi sinterizzati e procedimento per la loro produzione
IT1167678B (it) Procedimento perfezionato per la produzione di polifenilenossido
IT1151414B (it) Processo per la produzione di beta-idrossiaminoacidi
IT1198342B (it) Processo per la produzione di alfa-6-desossi-tetracicline
IT8219196A0 (it) Diidro-benzotiadiazepine e processo elettrochimico per la loro produzione.
IT1198035B (it) Metodo per la fabbricazione di filetti
IT8224364A0 (it) Metodo per la produzione di esaidro -5-idrossi-4-idrossimetil-2hciclopenta [b]-furan-2-onderivati

Legal Events

Date Code Title Description
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19970226